Retrospective Analysis of the Treatment Results for Patients with Squamous Cell Carcinoma of Tonsil

다국어 초록 (Multilingual Abstract)

Purpose: There has been no definitive randomized study to identify the optimal therapeutic regimen for treating squamous cell carcinoma of tonsil. The purpose of this study was to retrospectively evaluate the treatment outcome according to various combinations of surgery, radiation therapy and chemotherapy.Materials and Methods: Fifty-six patients with tonsillar carcinoma, who were treated at Seoul National University Hospital from March 1985 to August 2001, were the subjects of this study. Twenty-one patients received surgery followed by radiation therapy (SRT), 16 patients underwent radiation therapy alone (RT), and 19 patients received neoadjuvant chemotherapy and radiation therapy (CRT). The median radiation dose was 66.6 Gy for the SRT group and 70.2 Gy for the RT and CRT groups. Surgery comprised extended tonsillectomy and modified radical neck dissection of the involved neck.Cisplatin and 5-fluorouracil were used every three weeks for 3 cycles in the SRT group. The median follow-up was 73.2 months.Results: The distribution of T-stage was 4 cases of T1, 14 cases of T2, 1 case of T3 and 2 cases of T4 staging in the SRT group, 2 cases of T1, 6 cases of T2, 5 cases of T3 and 3 cases of T4 staging in the RT group and 0 cases of T1, 7 cases of T2, 9 cases of T3 and 3 cases of T4 staging in the CRT group. The distribution of N-stage was 5 cases of N0, 2 cases of N1, 13 cases of N2 and 1 case of N3 staging in the SRT group, 6 cases of N0, 5 cases of N1, 5 cases of N2 and 0 cases of N3 staging in the RT group, and 2 cases of N0, and 7 cases of N1, 9 cases of N2 and 1 case of N3 staging in the CRT group. The five-year overall survival rate (OSR) for all patients was 78%. The five-year OSR was 80% for the SRT group, 71% for the RT group, and 80% for the CRT group (p=ns). The five-year disease-free survival rate was 93% for the CRT group and 71% for the RT group (p=0.017).Four patients developed local failure and one patient failed at a regional site in the RT group, and one patient failed at a primary site in the CRT group. The five-year DFS was 84% for patients who had undergone neck dissection and 76% for patients who had not undergone neck dissection (p=ns). Treatment-related complications of grade 3 or 4 occurred in 15 patients, and the incidence of complication was not different between each of the treatment methods.Conclusion: Although the patients with more advanced T stage were included in the RT and CRT groups, the OSR was not statistically different according to the treatment methods. In the radical radiation therapy group, the addition of neoadjuvant chemotherapy showed an improvement in the disease-free survival. Because of the retrospective nature of our study and the small number of patients, this study cannot draw any definite conclusions, but it suggests that radiation therapy with chemotherapy can be a good alternative option for squamous cell carcinoma of tonsil. Controlled randomized study is necessary to confirm this hypothesis. (Cancer Res Treat.2005;37:92-97)

참고문헌 (Reference)

1 "Toxicity criteria of the radiation therpy oncology group and the european organization for research and treatment of cancer" 31 : 1341-6, 1995

2 "Tonsillar carcinoma:analysis of treatment results" 27 : 263-9, 1998

3 "Tonsil cancer" 141 : 11-4, 1989

4 "The treatment of squamous cell carcinoma of the tonsil with neck node metastases" 25 : 24-31, 2003

5 "The benefits and pitfalls of ipsilateral radiotherapy in carcinoma of the tonsillar region" 51 : 332 -43, 2001

6 "Statistical methods in medical research" 436-7, 1987

7 "Squamous cell carcinoma of the oropharynx:surgery,radiation therapy or both" 94 : 2967-80, 2002

8 "Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer:a randomized multicenter study" 16 : 1318-24, 1998

9 "Role of planned neck dissection for advanced metastatic disease in tongue base or tonsil squamous cell carcinoma treated with radiotherapy" 24 : 474-87, 2002

10 "Role of neck surgery in conjunction with radiation in regional control of node-positive cancer of the orophsarynx" 25 : 109-116, 2002

11 "Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma" 91 : 2081-6, 1999

12 "Patterns of failure after surgery alone and surgery combined with postoperative radiation therapy" 2638-47, 1994

13 "Mature results of a Phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck" 88 : 876-83, 2000

14 "Laryngeal preservation for advanced laryngeal and hypopharyngeal cancers" 121 : 219-23, 1995

15 "Induction chemotherapy and radiation therapy for T4 oropharyngeal carcinoma" 7 : 98-105, 1999

16 "Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck:a prospective randomized trial" 18 : 1458-64, 2000

17 "Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer" 338 : 1798-804, 1998

18 "Comparison of radiation therapy and combined chemotherapy and radiation therapy for locally advanced head and neck cancer" 29 : 616-22, 1997

19 "Combined radiation therapy and surgery in the management of advanced head and neck cancer:final report of study 73-03 of the Radiation Therapy Oncology Group" 10 : 19-30, 1987

20 "Chemotherapy added to locoregional treatment for head and neck squamouscell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapyon Head and Neck Cancer" 355 : 949-55, 2000

21 "Carcinoma of the tonsillar fossa:prognostic factors and long-term therapy outcome" 42 : 1077-84, 1998

22 "Calculation of confidence intervals for survival during analysis Statistics with confidence" 54-70, 1989

23 "AJCC Cancer Staging Manual (ed 6)." Lippincott-Raven 2002